315 related articles for article (PubMed ID: 28747065)
21. Cerebroventricular clozapine would be a viable treatment modality for clozapine-dependent schizophrenia patients with neutropenia.
Alisky JM
Med Hypotheses; 2012 Oct; 79(4):497-9. PubMed ID: 22818272
[TBL] [Abstract][Full Text] [Related]
22. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
Lally J; Malik S; Whiskey E; Taylor DM; Gaughran FP; Krivoy A; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Aug; 37(4):441-446. PubMed ID: 28437295
[TBL] [Abstract][Full Text] [Related]
23. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor.
Raison CL; Guze BH; Kissell RL
J Clin Psychopharmacol; 1994 Aug; 14(4):285-6. PubMed ID: 7525662
[No Abstract] [Full Text] [Related]
25. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series.
Béchard L; Morasse-Bégis M; Corbeil O; Hakim JR; Malenfant E; Brodeur S; Huot-Lavoie M; Essiambre AM; Demers MF; Roy MA
J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):391-395. PubMed ID: 35546087
[TBL] [Abstract][Full Text] [Related]
26. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
Joffe G; Eskelinen S; Sailas E
Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
[No Abstract] [Full Text] [Related]
27. Use of Granulocyte Colony-Stimulating Factor in a Neutropenic HIV-Infected Patient on Clozapine.
Elmore H; Lewin J; Bradley M; Sinkman A
Psychosomatics; 2016; 57(6):651-654. PubMed ID: 27720385
[No Abstract] [Full Text] [Related]
28. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
Majczenko TG; Stewart JT
South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report.
Spencer BW; Williams HR; Gee SH; Whiskey E; Rodrigues JP; Mijovic A; MacCabe JH
J Psychopharmacol; 2012 Sep; 26(9):1280-2. PubMed ID: 22719015
[TBL] [Abstract][Full Text] [Related]
30. Extended Requirement of Granulocyte Colony-Stimulating Factor for Clozapine-Associated Neutropenia.
Leppla IE; Nucifora FC; Sedlak TW
J Clin Psychopharmacol; 2019; 39(2):169-172. PubMed ID: 30811374
[No Abstract] [Full Text] [Related]
31. Clozapine-induced neutropenia in children: management with lithium carbonate.
Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
[TBL] [Abstract][Full Text] [Related]
32. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.
Dunk LR; Annan LJ; Andrews CD
Br J Psychiatry; 2006 Mar; 188():255-63. PubMed ID: 16507968
[TBL] [Abstract][Full Text] [Related]
33. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
Manu P; Lapitskaya Y; Shaikh A; Nielsen J
Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
[TBL] [Abstract][Full Text] [Related]
34. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
Rajagopal G; Graham JG; Haut FF
J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
[TBL] [Abstract][Full Text] [Related]
35. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
Manu P; Sarpal D; Muir O; Kane JM; Correll CU
Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
[TBL] [Abstract][Full Text] [Related]
36. Continuing clozapine treatment despite neutropenia.
Esposito D; Rouillon F; Limosin F
Eur J Clin Pharmacol; 2005 Jan; 60(11):759-64. PubMed ID: 15660271
[TBL] [Abstract][Full Text] [Related]
37. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
Gullion G; Yeh HS
J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
[TBL] [Abstract][Full Text] [Related]
38. Clozapine Rechallenge After Neutropenia or Leucopenia.
Prokopez CR; Armesto AR; Gil Aguer MF; Balda MV; Papale RM; Bignone IM; Daray FM
J Clin Psychopharmacol; 2016 Aug; 36(4):377-80. PubMed ID: 27232877
[TBL] [Abstract][Full Text] [Related]
39. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
40. Clozapine and chemotherapy: a dangerous couple or a necessary partnership?
Campbell G; Wong E
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
